Effect of Sex, Pubertal Stage, Body Mass Index, Oral Contraceptive Use, and C-reactive Protein on Vitamin D Binding Protein Reference Values

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2025 Mar 5

PMID 40041287

Authors

Philipp von Heimburg

Ronny Baber

Anja Willenberg

Philip Wolfle

Jurgen Kratzsch

Wieland Kiess

Mandy Vogel

Affiliations

Soon will be listed here.

Abstract

Objective: Vitamin D binding protein (DBP) regulates the transport and availability of vitamin D. We aimed to establish age- and sex-specific reference ranges for serum concentrations of DBP in healthy infants, children, and adolescents. In addition, we investigated DBP's associations with age, sex, puberty, body mass index (BMI), and oral contraceptive use.

Design And Methods: 2,503 serum samples from children and adolescents aged 3 months to 17 years from the LIFE Child cohort were analyzed to study DBP levels in this population (49.3% female subjects, 50.7% male subjects). Age- and sex-dependent reference percentiles were established using generalized additive models. We used linear mixed effects models to assess DBP's associations with age, sex, pubertal status, the BMI standard deviation score (SDS), and oral contraceptives. To investigate associations between DBP and vitamin D metabolites, we applied univariate regression analysis. We used hierarchical regression models and linear mixed effects models to assess DBP's associations with bone parameters, hormones, and inflammatory markers.

Results: Mean DBP values differed between males (347 mg/l) and females (366 mg/l) (p < 0.001). Age had no significant association with DBP levels. In both males and females, DBP levels remained relatively stable from infancy through late adolescence. Children and adolescents with obesity had lower mean DBP levels compared with normal-weight subjects (ß = -14.28, p < 0.001). The BMI-SDS was inversely associated with DBP levels in males (ß = -5.7, p < 0.001). Female subjects using oral contraceptives had higher levels of DBP (ß = 141.38, p < 0.001). DBP was positively associated with the vitamin D metabolites: 25(OH)D (females: ß = 0.8, p < 0.001; males: ß = 1.2, p < 0.001) and 1,25(OH)-D (females: ß = 0.3, p < 0.001; males: ß = 0.4, p < 0.001). An inverse association between osteocalcin and DBP (females: ß = -0.1, p < 0.022; males: ß = -0.1, p = 0.027) was found. CRP levels were also positively associated with DBP levels (females: ß = 2.8, p = 0.001; males: ß = 5.1, p < 0.001).

Conclusion: We established age- and sex-specific reference ranges for the serum concentration of DBP. We suggest that BMI, pubertal stages, oral contraceptive use, and inflammation markers need to be considered when interpreting DBP as a stabilizer and regulator of vitamin D metabolism and vitamin D status in children and adolescents.

Clinical Trial Registration: ClinicalTrial.gov, identifier NCT02550236.

References

Jain S, Gautam V, Naseem S . Acute-phase proteins: As diagnostic tool. J Pharm Bioallied Sci. 2011; 3(1):118-27. PMC: 3053509. DOI: 10.4103/0975-7406.76489. View

Bikle D, Gee E, Halloran B, Kowalski M, Ryzen E, Haddad J . Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986; 63(4):954-9. DOI: 10.1210/jcem-63-4-954. View

Wilson R, Bortner Jr J, Roff A, Das A, Battaglioli E, Richie Jr J . Genetic and environmental influences on plasma vitamin D binding protein concentrations. Transl Res. 2014; 165(6):667-76. DOI: 10.1016/j.trsl.2014.08.003. View

Giollabhui N, Ellman L, Coe C, Byrne M, Abramson L, Alloy L . To exclude or not to exclude: Considerations and recommendations for C-reactive protein values higher than 10 mg/L. Brain Behav Immun. 2020; 87:898-900. PMC: 7316621. DOI: 10.1016/j.bbi.2020.01.023. View

Gazarra L, Bonacordi C, Yela D, Benetti-Pinto C . Bone mass in women with premature ovarian insufficiency: a comparative study between hormone therapy and combined oral contraceptives. Menopause. 2020; 27(10):1110-1116. DOI: 10.1097/GME.0000000000001592. View

Guha C, Osawa M, Werner P, Galbraith R, Paddock G . Regulation of human Gc (vitamin D--binding) protein levels: hormonal and cytokine control of gene expression in vitro. Hepatology. 1995; 21(6):1675-81. View

Stanczyk F, Sriprasert I, Danis R, Pandian R, Matharu H, Bender N . Effect of oral contraceptives on total and bioavailable 25-hydroxyvitamin D. J Steroid Biochem Mol Biol. 2021; 211:105879. DOI: 10.1016/j.jsbmb.2021.105879. View

Bouillon R, Van Baelen H, DE MOOR P . 25-hydroxyvitamin D and its binding protein in maternal and cord serum. J Clin Endocrinol Metab. 1977; 45(4):679-84. DOI: 10.1210/jcem-45-4-679. View

Marshall W, Tanner J . Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970; 45(239):13-23. PMC: 2020414. DOI: 10.1136/adc.45.239.13. View

10.

Moller D, Flier J . Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med. 1991; 325(13):938-48. DOI: 10.1056/NEJM199109263251307. View

11.

Delanghe J, Speeckaert R, Speeckaert M . Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab. 2015; 29(5):773-86. DOI: 10.1016/j.beem.2015.06.006. View

12.

Dahl B, Schiodt F, Gehrchen P, Ramlau J, Kiaer T, Ott P . Gc-globulin is an acute phase reactant and an indicator of muscle injury after spinal surgery. Inflamm Res. 2001; 50(1):39-43. DOI: 10.1007/s000110050722. View

13.

Viloria K, Nasteska D, Briant L, Heising S, Larner D, Fine N . Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion. Cell Rep. 2020; 31(11):107761. PMC: 7302426. DOI: 10.1016/j.celrep.2020.107761. View

14.

Horvath-Szalai Z, Kustan P, Szirmay B, Lakatos A, Christensen P, Huber T . Predictive value of serum gelsolin and Gc globulin in sepsis - a pilot study. Clin Chem Lab Med. 2018; 56(8):1373-1382. DOI: 10.1515/cclm-2017-0782. View

15.

Walsh J, Evans A, Bowles S, Naylor K, Jones K, Schoenmakers I . Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. Am J Clin Nutr. 2016; 103(6):1465-71. DOI: 10.3945/ajcn.115.120139. View

16.

Horenz C, Vogel M, Wirkner K, Ceglarek U, Thiery J, Pfaffle R . BMI and Contraceptives Affect New Age-, Sex-, and Puberty-adjusted IGF-I and IGFBP-3 Reference Ranges Across Life Span. J Clin Endocrinol Metab. 2022; 107(7):e2991-e3002. DOI: 10.1210/clinem/dgac157. View

17.

Schmidt-Gayk H, Grawunder C, Tschope W, Schmitt W, Ritz E, Pietsch V . 25-hydroxy-vitamin-D in nephrotic syndrome. Lancet. 1977; 2(8029):105-8. DOI: 10.1016/s0140-6736(77)90118-0. View

18.

McDonnell D, Scott R, Kerner S, OMalley B, Pike J . Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression. Mol Endocrinol. 1989; 3(4):635-44. DOI: 10.1210/mend-3-4-635. View

19.

Marshall W, Tanner J . Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44(235):291-303. PMC: 2020314. DOI: 10.1136/adc.44.235.291. View

20.

Wiegratz I, Kutschera E, Lee J, Moore C, Mellinger U, Winkler U . Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception. 2003; 67(1):25-32. DOI: 10.1016/s0010-7824(02)00436-5. View